The Health Roundtable Limited
(ACN 071 387 436)
40 Port Jackson Road
Terrigal NSW 2260
Tel: 02 4385 5894
Fax: 02 4384 7078
Email: david.dean@healthroundtable.org
David J. H. Dean, Ph.D.
General Manager
26 July 2013
TO:
EXECUTIVE SPONSORS, LIAISON REPRESENTATIVES, MEDICAL
DIRECTORS, DIRECTORS OF CANCER SERVICES
SUBJECT:
Improving Management of Patients Living with Cancer [HRT1311]
Thursday 5 and Friday 6 Sept 2013, Melbourne
How well are you managing patients living with cancer?
Over 140,000 people are newly diagnosed with cancer every year in Australia and New Zealand. It
is estimated that over 1 million people are living who have had a previous diagnosis of cancer. Of
these cancer patients, 40% had prostate cancer and 20% had breast cancer.1 As patients
transition from the acute treatment phase, most service models continue to provide follow-up care
in the same acute setting. It is time to review whether this is the right approach for the future!
This Roundtable meeting will focus on long term management solutions for patients follow up with
a focus on prostate and breast cancer. The goal is to share practical ways to improve patient
transition from acute treatment settings into follow-up. We encourage each participant to share
initiatives and issues regarding the follow-up process.
The aims are:




To increase the efficacy and productivity of the oncology workforce in acute facilities.
Increase new patient access to oncology services.
Reduce variation in follow-up protocols to improve patient outcomes.
Identify and evaluate alternative models, including Wellness Centres.
There are two components to the fee structure for this Roundtable:
1. The organisational fee for the Roundtable meeting is $5,000 (plus GST) per organisation,
which includes the cost of analysing your inpatient data, the attached survey and facilitating
the meeting. A reduced rate of $3,000 plus GST is available for additional facilities within your
health service that want to complete the survey and participate in the meeting.
2. The delegate fee of $230 plus GST per person covers the cost of the hotel meeting facilities
and refreshments for the two days.
Please review the attached materials and let me or Kate Tynan know by 5 August if your
organisation is interested in participating in this important Roundtable meeting on 5-6 September
at the Novotel on Collins in Melbourne.
Best regards,
David Dean
1
AIHW estimate for Australia, extrapolated to include New Zealand.
AGENDA
ROUNDTABLE: IMPROVING MANAGEMENT OF PATIENTS LIVING WITH CANCER [HRT1311]
THE NOVOTEL ON COLLINS, 270 COLLINS STREET, MELBOURNE
WEDNESDAY 4 SEPTEMBER 2013
1.30 – 2.00pm
Welcome and Introductions
2.00 – 4.30pm
Optional Tour of Olivia Newton John Centre - Austin Health,
Heidelberg
THURSDAY 5 SEPTEMBER 2013
8.30 – 9.00am
Registration and arrival tea/coffee
9.00 – 10.30am
Welcome & Overview
Thought-Starter Presentation: Professor Bob Thomas Chief
Clinical Advisor for Cancer and Chair of the Advisory Council of the
Victorian Cancer Agency “Imperatives for change”
Recap Olivia Newton John Centre Tour - Key Points
Review of Pre-meeting Survey and Data on Current Practices
10.30 – 11.00am
Morning Tea
11.00 – 12.30pm
Small Group Discussion:
What will be “good practice” in 2020?
12.30 – 1.30pm
Lunch
1.30 – 4.00pm
Poster Presentations and Discussion:
Innovations in management of patients living with cancer (including
afternoon tea break)
4.00 – 4.30pm
Health Service team discussions:
What “bright spots” have we found?
What Hot Issues to resolve?
4.30pm
Meeting Closes
6.30pm
Group Dinner: Bluestone Restaurant, Flinders Lane
FRIDAY 6 SEPTEMBER 2013
9.00 – 9.30am
Review of Bright Spots and Hot Issues
9.30 – 10.30am
Hot Issue Forum:
Sharing insights and ideas with each other to resolve specific issues
10.30 – 11.00am
Morning Tea
11.00 – 12.00 noon
Recap of Hot Issue solutions
12.00 – 1.00pm
Health Service Action Planning:
Developing specific improvement projects to improve management of
patients living with cancer
Next Steps
1.00 – 2.00pm
Lunch
2.00 – 3.30pm
Optional Workshop:
Using LEAN techniques to improve the cancer journey
3.30pm
Meeting Closes
 Copyright 2013 The Health Roundtable Ltd
Page 2
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Prof Bob Thomas
Acting Chief Executive Officer Peter Mac Callum Cancer Centre Aug 2013
Chief Clinical Advisor for Cancer and Chair of the Advisory Council of the Victorian Cancer Agency
Professor Bob Thomas graduated from Medicine from the University of Melbourne and trained in
surgery at the Royal Melbourne Hospital. He was Professor and Director of Surgical Oncology at
the Peter Mac Callum Cancer Centre and in 2009 was appointed the Victorian government’s Chief
Clinical Advisor for Cancer and Chair of the Advisory Council of the Victorian Cancer Agency.
Professor Thomas has been heavily involved in the development of cancer reforms within
Australia. He is passionate about cancer reform, working to provide all Victorians with the benefits
of multidisciplinary care, appropriate psychosocial support for cancer patients and carers and
access to the best translational research
 Copyright 2013 The Health Roundtable Ltd
Page 3
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
SUBSCRIPTION
THE HEALTH ROUNDTABLE
Improving Management of Patients Living with Cancer [2013R1]
Please return by email or fax to +61 (0)2 4384 7078
david.dean@healthroundtable.org
Note delegate fees are billed separately.
TO:
David Dean, General Manager, The Health Roundtable Limited
My organisation would like to subscribe to the following event:
Activity
Improving Acute Cancer Services:
Alternative follow-up care and wellness R1
Health Service
Name
My organisation agrees to subscribe to this Health Roundtable activity. I understand that the
information provided is subject to The Health Roundtable Honour Code, which requires that
participants will not use the information to the detriment of another member, and that no
disclosure of the survey or results of the meeting will be provided to non-members (unless
required by law) without the consent of all participants.
Organisational Participation Fee
$5,000 plus GST Main facility
Additional facilities within the same network
$3,000 plus GST (AUD$3,300)
Facility
$3,000 plus GST (AUD$3,300)
Facility
$3,000 plus GST (AUD$3,300)
Facility
$3,000 plus GST (AUD$3,300)
Facility
$3,000 plus GST (AUD$3,300)
Facility
Name:
Name:
Name:
Name:
Name:
Contact email and phone
Executive Sponsor Name
Email:
Phone:
Signature:
...................................................
Date:..........................................
Lead Delegate Name
 Copyright 2013 The Health Roundtable Ltd
Email:
Phone:
Page 4
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
DELEGATE REGISTRATION DETAILS
ROUNDTABLE: IMPROVING MANAGEMENT OF PATIENTS LIVING WITH CANCER [2013R1]
THURSDAY 5 & FRIDAY 6 SEPTEMBER 2013 MELBOURNE
PLEASE USE OUR WEBSITE TO REGISTER, AT WWW.HEALTHROUNDTABLE.ORG
CLICK ON “ATTEND EVENT – MEETING REGISTRATION” – THEN FIND MEETING CODE HRT1311
Use this form only if you are unable to register online.
ORGANISATION NAME
Chief Delegate #1 Name
Position
Phone
Email
Please tick if you will be attending OLIVIA NEWTON JOHN CENTRE Tour 4 September
Please tick if you will be attending the Dinner on 5 September 2013
Delegate #2 Name
Position
Phone
Email
Please tick if you will be attending OLIVIA NEWTON JOHN CENTRE Tour 4 September
Please tick if you will be attending the Dinner on 5 September 2013
Delegate #3 Name
Position
Phone
Email
Please tick if you will be attending OLIVIA NEWTON JOHN CENTRE Tour 4 September
Please tick if you will be attending the Dinner on 5 September 2013
Delegate #4 Name
Position
Phone
Email
Please tick if you will be attending OLIVIA NEWTON JOHN CENTRE Tour 4 September
Please tick if you will be attending the Dinner on 5 September 2013
2-Day Conference Package includes all Conference Facilities, refreshments and lunches.
4/9/2013 Tour: OLIVIA
NEWTON JOHN CENTRE
No. of Delegates attending
AUD$ 0.00
2 Day Conference Package
No. of Delegates attending
@ AUD$230.00 + GST (A$253) per person = AUD$
Dinner - 5 September
No. of Delegates attending
@ AUD$70.00 + GST (A$77) per person = AUD$
TOTAL TO PAY BY 20 August 2013 – AUD$
PLEASE NOTE: This is not a Tax Invoice – if you are unable to register on the website please complete
and fax to The Health Roundtable (02 4384 7078) or email to: kate.tynan@healthroundtable.org by 20
August 2013. When we receive this form a Tax Invoice will be emailed to you.
Delegate Registrations may be cancelled up to 29 August 2013, with a full credit of monies paid. After that date,
no credits are possible. However, you may substitute a different person for those registered at any time. Hotel and
airfare arrangements are separate, and may have different policies regarding cancellations and name changes.
Please contact them directly.
 Copyright 2013 The Health Roundtable Ltd
Page 5
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Accommodation and Travel Arrangements
Delegates are responsible for making their own accommodation and travel/flight arrangements.
The Novotel Melbourne on Collins has set aside rooms for the nights of 4 & 5 September 2013
for The Health Roundtable as follows:
Room Type
Room rate breakfast x 1
Standard Room (Single)
$227
Premier Room (includes complimentary internet, local phone calls and bottled water) $257
Executive Suite
$297
The above rates are inclusive of GST and based on single occupancy per room per night and include
a full buffet breakfast in Michel’s Restaurant. (A $20 surcharge applies for twin share).
Please note that all quoted Room & Breakfast Package rates must be pre-booked and confirmed
through reservation at the time of booking and are not available upon check-in to the hotel directly.
Buffet breakfast is $29 per person per day, if required once guest is checked in.
Delegates may contact the hotel direct on +61 3 9667 5800 and speak to Reservations, or
email H1587@accor.com and quote THE HEALTH ROUNDTABLE BLOCK ID: 156451 to receive
the conference rate.
Alternatively, delegates can book online – click here to make your reservation and access the
special Health Roundtable rates.
To reserve one of these rooms please book before 4 August 2013
Any additional room nights required after this date will be subject to hotel availability
at the time of booking.
Cancellation policy:
No cancellation charge applies prior to 18:00 (local time), up to 1 day prior to arrival. Beyond
that time, the first night will be charged.
270 Collins St, Melbourne VIC 3000
 Copyright 2013 The Health Roundtable Ltd
Page 6
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
IMPROVING MANAGEMENT OF PATIENTS LIVING WITH CANCER
5 & 6 SEPTEMBER 2013 [HRT1311]
Optional Tour of Olivia Newton John Centre on 4 September 2013
PRE-MEETING SURVEY INSTRUCTIONS
The survey must be completed electronically. Please enter your responses in the shaded boxes in
each section. Space for responses will automatically expand to handle all of the text you enter –
ignore how this impacts on the pagination or other layout. If you have additional attachments to
support your survey responses, please send them as email attachments and cross-reference their
file names on the survey.
Please involve the delegates attending the meeting in the completion of this self-assessment
survey and a review of the responses. If you are unsure of the answer to a question, please make
a “guesstimate” rather than leave a blank. The survey information will be used only within the
Roundtable and will not be released externally without the unanimous consent of the participating
organisations.
Please complete the Survey and email it to the address below no later than 15 August
2013. PLEASE RETURN A WORD VERSION --- DO NOT SAVE AS A PDF
Return the survey to:
survey@hrt.org.au
ORGANISATION NAME:
NAME OF NETWORK/DISTRICT:
PLEASE NOMINATE SOMEONE FOR US TO CONTACT IN CASE WE HAVE ANY QUERIES
WITH THIS RETURNED COMPLETED SURVEY:
NAME:
POSITION:
PHONE:
EMAIL:
 Copyright 2013 The Health Roundtable Ltd
Page 7
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 1: YOUR CANCER SERVICE
Your Cancer Service
1.1 Does your health service have a comprehensive cancer service
providing sub-specialised medical & radiation oncology, allied
health and supportive care - treating the majority of cancer
types?
If YES, name:
OR
Yes
No
If NO, is your health service affiliated or networked with a
comprehensive cancer service?
If YES, name:
Yes
No
1.2 How are patients receiving chemotherapy treatments typically counted in your
health service?
Inpatient
Public Outpatient
Private non-inpatient
1.3 Does your health service provide radiation oncology services?
If YES, are medical and radiation oncology services collocated?
Yes
No
Yes
No
Yes
No
Yes
No
1.4 What year did your medical oncology service commence?
1.5 What year did your radiation oncology service commence?
1.6 Does the cancer service have formal partnerships with private
providers of oncology services e.g. Genesis Cancer Care?
If YES, please describe:
If YES, are there arrangements in place with these providers to
participate in and refer patients to multidisciplinary care meetings?
1.7 What was the total volume of new and follow-up patients with at least one
treatment or visit between 1 July 2012 and 30 June 2013?
New
Patients*
Follow-up
Patients**
New: Follow
up Ratio***
Radiation Oncology Service
Medical Oncology Service (excluding
Haematology patients)
Haematology Service (Malignancy)
*New patient consultation – first visit with an oncologist.
**Follow-up patients are those with appointments at prescribed intervals for the purpose of
managing the short and long term side effects (psychosocial and/or physical) of treatment and
should it occur, early detection of recurrence.
*** If you cannot determine from a data source -please estimate.
 Copyright 2013 The Health Roundtable Ltd
Page 8
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 2. GOOD PRACTICE INDICATORS 2013
Good Practice Indicators
Cancer Service Standards
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
2.6 Do MDTs meet at least fortnightly to discuss Breast, Urology
(Prostate), Lung and Colorectal Cancer patients?
Yes
No
2.7 Do all patients have a documented individual care plan
developed with the input of the MDT prior to treatment
commencing?
Yes
No
Yes
No
Yes
No
Yes
No
2.1 Has your government published current minimum Cancer
Services Standards?
Service Standards comments:
Leadership
2.2 There is an overall Director of Cancer Services:
Leadership comments:
Access
2.3 Do you measure New Patient waiting time from
booking/referral date to the appointment?
If YES, what is your target maximum waiting time to first appointment?
2.4 Do you measure Time from patient ‘ready to treat’ to
‘treatment start’ ?
If YES, what is your target maximum waiting time to treatment start?
Access comments:
Care Co-ordinator Services
2.5 Do you provide care coordinators to help patients navigate the
service?
If YES, are all patients screened to determine requirements for care
co-ordinator services?
Care Co-ordinator comments:
Multi-disciplinary Team Care
Multi-disciplinary Team Care comments:
Psychosocial/supportive care
2.8 Are all patients screened for psychosocial distress/supportive
care needs?
Psychosocial/supportive care comments:
Information Management
2.9 Does the cancer service have an integrated electronic
information management system including the patient's
medical record?
Information Management comments:
Consumer Engagement
2.10 Are consumers represented on committees for cancer service
planning, delivery and evaluation?
 Copyright 2013 The Health Roundtable Ltd
Page 9
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
2.11 Does the cancer service routinely collect patient feedback on
their experience of care?
If yes, please describe approach and collection frequency:
Yes
No
Yes
No
Consumer Engagement comments:
Clinical trials
2.12 Are rates of participation in clinical trials regularly evaluated
and reported for each tumour program?
Clinical Trials comments:
 Copyright 2013 The Health Roundtable Ltd
Page 10
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 3: UROLOGY (PROSTATE CANCER) PROGRAM
Radiation Oncology Service July 2012-Jun 2013: Localised Prostate Cancer Patients
3.1 How many new patients during the year?
3.2 How many follow-up patients were seen at least once during the
year?
3.3 What is the ratio of new to follow-up patients?
3.4 How many years, on average, do you aim to follow up localised
prostate cancer patients?
years
3.5 What % of patients would be considered by your service to be
lost to follow-up at 3 years? (Approximate)
3.6 Does the service actively seek to contact ‘lost to follow up’
patients?
%
Yes
No
RADIATION ONCOLOGY Prostate Cancer Patients attending in the week 3-7 June 2013
3.7 For New Patients: what was the average waiting time from
request to the first appointment?
days
3.8 What was the average waiting time from’ ready to treat’ to
treatment commencement’?
days
3.9 Is waiting time for new patient appointments a cause of
complaint in your organisation?
Yes
No
3.10 Is time spent waiting for appointments in the waiting room a
cause of complaint in your organisation (i.e. clinicians running
late)?
Yes
No
Case Study: Jack aged 60 had localised prostate cancer and was treated with radiation
therapy for cure. He remains well with PSA undetectable on his first post-treatment
visit. What is usual for further follow-up visits?
3.11 Is there an agreed follow-up protocol?
If YES please attach: File name of Attachment:
Yes
No
3.12 Would Jack have a written follow-up plan?
Yes
No
3.13 Would the radiation oncologist consult at the majority of
follow-up visits?
Yes
No
3.14 Will Jack be formally discharged from the cancer service for
follow-up with his GP?
Yes
No
If YES when?
If NO why not?
Comments:
3.15 How often would Jack receive a follow-up appointment in your service?
In the first 12 months:
In year 2:
In year 5:
In year 10:
Do all radiation oncologists in your service adhere to the same follow-up
schedules?
Yes
No
Does the patient also follow-up with the referring urologist?
If YES please comment:
Yes
No
 Copyright 2013 The Health Roundtable Ltd
Page 11
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
Other comments:
3.16 EXPERT OPINION- Please offer your opinion on
optimal care for patients like Jack
a.
Follow-up care should be protocol driven according to
risk
b.
Follow-up of cancer patients in the cancer centre setting
is the most appropriate setting
c.
The specialist oncologist should always consult patients
for follow-up at every visit
d.
The specialist oncologist should retain responsibility for
follow-up patients – but delegate this to a registrar
e.
The specialist oncologist should retain responsibility for
follow-up patients - but delegate this to a nurse
f.
Follow-up care could be fully devolved to specially trained
nurses
g.
Follow-up care could be devolved to other staff in a
separate facility other than the cancer centre
h.
Follow-up care could be devolved to the patient’s GP at
the completion of the final treatment review
i.
GPs must be formally trained/credentialed to undertake
follow-up
j.
The GP’s Practice Nurse must be formally
trained/credentialed to undertake follow-up
k.
Devolving follow-up care to other organisations would
compromise data capture of long term clinical outcomes
l.
Devolving follow-up care to other organisations would
impact on our monitoring of clinical trials and outcomes
m.
Devolving follow-up care would increase patients lost to
follow-up
n.
Devolving follow-up care would have a negative impact
on registrar training
o.
Devolving follow-up care would improve access for new
patients? (reduce waiting times for new appointments)
p.
Devolving follow-up care would free oncologists
maximise their expertise for new patients?
q.
Devolving follow-up care would create capacity in the
acute cancer facility
Agree
No
opinion
Disagree
Comments:
3.17 Do you know of any major innovations for improving
management of patients like Jack, living with cancer that has
been implemented in the last two years, anywhere in the world?
Please share with your colleagues:
Yes
No
3.18 Have you implemented innovations for follow-up care for prostate cancer in the
past 2 years?
If YES, please describe briefly:
Also, please prepare a short PowerPoint presentation for the workshop using the
template provided.
 Copyright 2013 The Health Roundtable Ltd
Page 12
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 4: BREAST CANCER PROGRAM
Medical and Radiation Oncology Service July 2012-Jun 2013: Localised Breast
Cancer Patients
4.1 How many new radiation oncology patients during the year?
4.2 How many follow-up radiation oncology patients were seen at
least once during the year?
4.3 What is the ratio of new to follow-up radiation oncology
patients?
4.4 How many years, on average, do you aim to follow up radiation
oncology breast cancer patients?
years
4.5 How many new medical oncology patients during the year?
4.6 How many follow-up medical oncology patients were seen at
least once during the year?
4.7 What is the ratio of new to follow-up medical oncology patients?
4.8 How many years, on average, do you aim to follow up medical
oncology breast cancer patients?
4.9 What % of patients would be considered by your service to be
lost to follow-up at 3 years? Approximate
4.10 Does the service actively seek to contact ‘lost to follow up’
patients?
years
%
Yes
No
MEDICAL ONCOLOGY Breast Cancer Patients attending in the week 3-7 June 2013
4.11 For New Patients: What was the average waiting time from
request to the first appointment?
days
4.12 What was the average waiting time from 'ready to treat’ to
treatment commencement’?
days
4.13 Is waiting time for new patient appointments a cause of
complaint in your organisation?
Yes
No
4.14 Is time spent waiting for appointments in the waiting room a
cause of complaint in your organisation i.e. clinicians running
late?
Yes
No
Case Study: Mary aged 54 completed surgery, radiation & chemotherapy treatment
for localised breast cancer and remains well. What is usual for follow-up visits?
4.15 Is there an agreed follow-up protocol? If yes please attach
Yes
No
4.16 Would Mary have a written follow-up plan?
Yes
No
4.17 Would an oncologist consult at the majority of follow-up visits?
Yes
No
Yes
No
Would Mary follow-up with the Radiation or Medical Oncologist?
Please comment:
4.18 Will Mary be formally discharged from the cancer service for
follow-up with her GP?
If YES when?
If NO why not?
Comments:
4.19 How often would Mary receive a follow-up appointment in your service?
In the first 12 months:
 Copyright 2013 The Health Roundtable Ltd
Page 13
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
In year 2:
In year 5:
In year 10:
Do all oncologists in your service adhere to the same follow-up
schedules?
Yes
No
Does the patient also follow-up with the referring surgeon?
If yes please comment:
Yes
No
Other comments:
4.20 EXPERT OPINION- Please offer your opinion on
optimal care for patients like Mary
a.
Follow-up care should be protocol driven according to
risk
b.
Follow-up of cancer patients in the cancer centre setting
is the most appropriate setting
c.
The specialist oncologist should always consult patients
for follow-up at every visit
d.
The specialist oncologist should retain responsibility for
follow-up patients – but delegate this to a registrar
e.
The specialist oncologist should retain responsibility for
follow-up patients - but delegate this to a nurse
f.
Follow-up care could be fully devolved to specially trained
nurses
g.
Follow-up care could be devolved to other staff in a
separate facility other than the cancer centre
h.
Follow-up care could be devolved to the patient’s GP at
the completion of the final treatment review
i.
GPs must be formally trained/credentialed to undertake
follow-up
j.
The GP’s Practice Nurse must be formally
trained/credentialed to undertake follow-up
k.
Devolving follow-up care to other organisations would
compromise data capture of long term clinical outcomes
l.
Devolving follow-up care to other organisations would
impact on our monitoring of clinical trials and outcomes
m.
Devolving follow-up care would increase patients lost to
follow-up
n.
Devolving follow-up care would have a negative impact
on registrar training
o.
Devolving follow-up care would improve access for new
patients? (reduce waiting times for new appointments)
p.
Devolving follow-up care would free oncologists maximise
their expertise for new patients?
q.
Devolving follow-up care would create capacity in the
acute cancer facility
Agree
Disagree
No
opinion
Comments:
4.21 Do you know of any major innovations for improving management of patients
 Copyright 2013 The Health Roundtable Ltd
Page 14
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
like Mary, living with cancer that has been implemented in the last two years,
anywhere in the world?
Please share with your colleagues:
4.22 Have you implemented innovations for breast cancer follow-up care in the past
2 years?
If yes, please describe briefly:
Also, please prepare a short PowerPoint presentation for the workshop using the
template provided
 Copyright 2013 The Health Roundtable Ltd
Page 15
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 5: WELLNESS DURING & AFTER CANCER TREATMENT
5.1 Are Wellness Centres desirable for a patient centred cancer
service?
Yes
No
5.2 Does your organisation have a Wellness Centre?
Yes
No
5.3 Is your service planning to establish a Wellness Centre?
If so when?
Yes
No
5.4 Should a Wellness Centres be co-located with the acute cancer
service?
Yes
No
5.5 Should patients ever be discharged from the Wellness Centre?
Yes
No
5.6 If you have a Wellness Centre or are planning one, how is it funded (or planning
to be funded?)
a.
Is there (or would there be) a charitable foundation associated with
the centre?
b.
CAPITAL Sources - select approximate percentage:
Philanthropy
Please select:
Government Grant
Please select:
Health Service
Please select:
Other:
Please select:
c.
Total budget build approx.
d.
Total budget fitout approx.
e.
OPERATING COSTS select approximate percentage
Philanthropy
Please select:
Government grant
Please select:
Health Service
Please select:
Medicare Billing
Please select:
Patient/User contribution
Please select:
Other:
Please select:
f.
Total operating budget 12/13 approx.
g.
STAFFING select approximate percentage
Health Service Staff
Please select:
Other salaried staff
Please select:
Fee for service care providers
Please select:
Volunteers
Please select:
Other:
Please select:
5.7 What services are provided by your cancer service ?
a.
Yes
No
Are any of these
delivered through the
Wellness Centre?
CLINICAL SERVICES
Patient transition programs post acute care
Yes
No
Yes
Rehabilitation programs
Yes
No
Yes
Routine follow up clinics
Yes
No
Yes
Special clinics - lymphedema, continence
Yes
No
Yes
 Copyright 2013 The Health Roundtable Ltd
Page 16
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
Psychosocial support and counselling
Yes
No
Yes
Palliative and supportive care services
Yes
No
Yes
Other:
b.
Yes
PRACTICAL PLANNING
Advance Directives
Yes
No
Yes
Estate planning
Yes
No
Yes
Other:
c.
Yes
COMPLEMENTRY THERAPIES
Massage
Yes
No
Yes
Yoga
Yes
No
Yes
Pilates
Yes
No
Yes
Reiki
Yes
No
Yes
Reflexology
Yes
No
Yes
Aromatherapy
Yes
No
Yes
Other:
Yes
Comments:
 Copyright 2013 The Health Roundtable Ltd
Page 17
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013
SECTION 6: HOT TOPICS
List up to three key cancer issues you would like to discuss with your colleagues at
the meeting?
Ideally these should relate to practical ways to improve your service or deal with a
specific issue.
1. How to:
2. How to:
3. How to:
 Copyright 2013 The Health Roundtable Ltd
Page 18
HRT1311 – 5 & 6 September 2013, Melbourne
Improving Management of Patients Living with Cancer
Please return to: survey@hrt.org.au by 15 August 2013